Updated treatment protocol for direct-acting antiviral agents for hepatitis C
ZHANG Xia-xia
XU Xiao-yuan
Abstract：A relatively complete hepatitis C guideline updated by the American Society for Study of Liver Diseases and the In-fectious Diseases Society of America was published in Hepatology on June 30, 2015. In this guideline, consensus on recommendations for treating adults infected with HCV is reached. The choice of direct-acting antiviral agents (DAAs) may involve the consideration of HCV genotype, prior treatment response, DAA-resistance mutations, etc., so as to optimize treatment options and improve antiviral effi-cacy. Meanwhile, standardizing the rational use of DAAs in clinical practice may prevent drug resistance and reduce cost of treatment.
Keywords：hepatitis Cantiviral agentsguidebookssocietiesclinical protocols
Publication Date：2015-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：3( 197-199 )